No abstract available
MeSH terms
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use*
-
Azetidines / therapeutic use
-
Benzylamines
-
Clinical Trials, Phase III as Topic
-
Drug Design
-
Factor Xa Inhibitors
-
Follow-Up Studies
-
Fondaparinux
-
Humans
-
Polysaccharides / administration & dosage
-
Polysaccharides / therapeutic use
-
Randomized Controlled Trials as Topic
-
Recurrence
-
Thromboembolism / drug therapy*
-
Thromboembolism / etiology
-
Thromboembolism / prevention & control
-
Thrombophilia / complications
-
Venous Thrombosis / drug therapy*
-
Venous Thrombosis / etiology
-
Venous Thrombosis / prevention & control
-
Vitamin K / antagonists & inhibitors
Substances
-
Anticoagulants
-
Azetidines
-
Benzylamines
-
Factor Xa Inhibitors
-
Polysaccharides
-
Vitamin K
-
ximelagatran
-
Fondaparinux